It's up to the Chair.
Yes, go on.
Is that all right? Sorry, I know it's a very long answer. There is a concern from the neurodevelopmental group to get across that whilst there has been a lot of focus on autism—and we recognise the private Member's Bill—there are other neurodevelopmental presentations and there's a real—. Having the broadest view would be advised by them, and I think they're particularly keen to understand what a future vision and what we call, say, a 'perfect world' would look like. That's the piece of work that we're wanting to do now. In terms of giving advice at the end of the programme and into legacy arrangements, about what the big, big things are, we are still needing to tackle.
I mean, I personally took a very personal decision when it came to the Member's Bill on autism you were talking about—and that was the advice I received. You need to look at the wider symptoms that are presented beyond autism and other neurological conditions. So, I'm glad you said that, because it gives me—. Because I didn't vote for that Bill, and I'm glad you said that because it gives me some personal reassurance there. But what I do have concerns about is if the increase wasn't anticipated to the extent that it was and that the Together for Children and Young People programme has a duty to review capacity, after October who's going to make sure that that capacity's reviewed on a strategic basis?